Search

1222498
1201004
1195994
393884
209802
ScimathUS
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.

News

Wednesday, 17 January 2018
8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis

Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

Publication Date:
Friday, September 8, 2017 - 08:00
7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire

Associate Professor Tom Scriba has co-authored a research paper titled "Identifying specificity groups in the T Cell receptor repertoire" appearing in the Nature Journal.

Publication Date:
Thursday, September 7, 2017 - 17:15
6 September 2017 Research Published: Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice

SATVI authors Associate Professor Tom Scriba, Dr Stanley Mbandi Kimbung, Fatoumatta Darboe and Dr Adam Penn-Nicholson have co-authored a paper titled "Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice" appearing in the Mucosol Immunology Journal.

Publication Date:
Wednesday, September 6, 2017 - 20:15
6 September 2017 SATVI marks 3000th patient screened in CORTIS HR study.

SATVI recently marked the 3 000th patient who had been screened for participation in the Correlates of Risk of TB study (CORTIS-01).  

Publication Date:
Wednesday, September 6, 2017 - 19:00

Pages